EnGenes Biotech
EMEA
Vienna
,
Austria
Startup
FOUNDED
2014
HEADCOUNT
2-20
FUNDING
Undisclosed
Keywords:
CDMO, CRO, bacteria, continuous_bioprocessing, DNA_synthesis, therapeutics, diagnostics
BUSINESS
Develops microbial expression systems and provides bioprocessing services for recombinant protein and plasmid DNA production for pharmaceutical, diagnostic, and industrial clients. enGenes Biotech is a contract research, development, and manufacturing company founded in 2014 as a spin-off from BOKU University Vienna, based in Vienna, Austria. The company offers E. coli-based expression and bioprocess development services from microscale through pilot scale (~150 L)
BIOTECH INVOLVEMENT
Core; Vienna-based CRDMO (2014) developing proprietary growth-decoupled microbial platforms (enGenes-eXpress) for recombinant protein and plasmid DNA production, including continuous manufacturing approaches for pharma, diagnostic, and industrial customers.
TECHNOLOGY PLATFORM
enGenes-eXpress/eXtra/eXcite platforms; microbial fermentation
PRIMARY PRODUCTS
Recombinant proteins; plasmid DNA; eXrase endonuclease; eXfinity affinity ligands; custom bioprocess services